Alira Health

Alira Health

Cardiology Medical Devices Market Trends 2023 is released in the United States and Europe

The state-of-the-art study examines tangible insights on the landscape and outlook of the cardiology market conducted by Alira Health

Published on:
June 26, 2023

FRAMINGHAM, Mass. – June 26, 2023 – Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announced today the release of the Cardiology Medical Devices Market Trends 2023 in collaboration with MassMEDIC, the Massachusetts Medical Device Industry Council, the largest regional medtech association in the United States. The report explores the existing market growth trends, areas of investment, and outlook, resulting from the research, data collection and forecasts conducted by Alira Health. The thorough analysis of the cardiology medical devices market includes insights into the key market drivers and restraints, including the cardiology market foundations, cardiology clinical and market landscape today, and cardiology market outlook.

The patient population experiencing heart disease is expected to experience strong growth relative to other adjacent patient populations due to the aging US and EU populations, and the increasing obese and overweight population in both regions. Each of these comorbidities (age and BMI) are associated with an increased risk of heart disease and are expected to drive incidence growth through the decade.

Across the US and the EU, the Cardiology Medical Devices Market totaled $34.3 billion in 2022 and is forecasted to grow to $46.4 billion by 2027 at a CAGR of 6.2% (’22-’27). The largest segment of the market in 2022 was Structural Heart. Not only is this growth expected to remain constant in the future, Structural Heart is also expected to be the fastest growing segment of the Cardiology Medical Devices Market.

Several key trends are expected to have a significant impact on the Cardiology Medical Devices Market, including an increasing shortage of cardiologists, increasingly miniaturized devices to improve device use, access, and patient outcomes, and the shift of cardiology procedures from traditional inpatient settings to Ambulatory Surgery Centers (ASCs).



About Alira Health

Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare. We work with healthcare and life sciences organizations looking for support across their entire solutions lifecycle. From development to medical care, we complement our clients’ expertise with a full spectrum of services including research and clinical development solutions, technology-powered consulting, and real-world evidence. Alira Health’s integrated and multidisciplinary team of over 800 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50% of MedTech companies and 75% of the top 50% of Pharma companies.

Cardiac Medical Devices Market

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.